CSHB 240(FIN): "An Act relating to prescription prices available to consumers; relating to penalties for certain pharmacy or pharmacist violations; relating to the registration and duties of pharmacy benefits managers; relating to procedures, guidelines, and enforcement mechanisms for pharmacy audits; relating to the cost of multi-source generic drugs and insurance reimbursement procedures; relating to the duties of the director of the division of insurance; and providing for an effective date."
00 CS FOR HOUSE BILL NO. 240(FIN) 01 "An Act relating to prescription prices available to consumers; relating to penalties for 02 certain pharmacy or pharmacist violations; relating to the registration and duties of 03 pharmacy benefits managers; relating to procedures, guidelines, and enforcement 04 mechanisms for pharmacy audits; relating to the cost of multi-source generic drugs and 05 insurance reimbursement procedures; relating to the duties of the director of the 06 division of insurance; and providing for an effective date." 07 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA: 08 * Section 1. AS 08.80.297 is amended by adding a new subsection to read: 09 (b) No contract or agreement may prohibit a pharmacy, pharmacist, or 10 pharmacy benefits manager from informing a patient of a less costly alternative for a 11 prescription drug or medical device or supply, which may include the amount the 12 patient would pay without the use of a health care plan. 13 * Sec. 2. AS 08.80.297 is amended by adding new subsections to read:
01 (c) A pharmacist or person acting at the direction of a pharmacist shall notify 02 the patient if a known less costly alternative for a prescription drug or medical device 03 or supply is available, which may include the amount the patient would pay without 04 the use of a health care plan. 05 (d) In this section, 06 (1) "health care plan" means a policy, contract, benefit, or agreement 07 that provides, delivers, arranges for, pays for, or reimburses any of the costs of health 08 care services under 09 (A) a health care insurance plan as defined under 10 AS 21.54.500; 11 (B) a governmental or employee welfare benefit plan under 29 12 U.S.C. 1001 - 1191 (Employee Retirement Income Security Act of 1974); 13 (C) a plan offered under AS 39.30.090 or 39.30.091; 14 (D) a federal governmental plan as defined under 15 AS 21.54.500; 16 (E) the Medicaid or Medicare program; or 17 (F) a self-insured employer benefit plan; 18 (2) "pharmacy benefits manager" has the meaning given in 19 AS 21.27.955. 20 * Sec. 3. AS 08.80.460(a) is amended to read: 21 (a) Except for a violation of AS 08.80.297, a [A] person who violates a 22 provision of this chapter is guilty of a class B misdemeanor. 23 * Sec. 4. AS 08.80.460(b) is amended to read: 24 (b) A person who violates the provisions of AS 08.80.295 or 08.80.297 may 25 be punished [IS PUNISHABLE] by a civil fine in an amount established by the board 26 in a schedule or schedules establishing the amount of civil fine for a particular 27 violation. The schedule or schedules shall be adopted by the board by regulation. Any 28 civil fine imposed under this section may be appealed in the manner provided for 29 appeals in AS 44.62 (Administrative Procedure Act). 30 * Sec. 5. AS 21.27 is amended by adding new sections to read: 31 Article 10. Pharmacy Benefits Managers.
01 Sec. 21.27.901. Registration of pharmacy benefits managers; scope of 02 business practice. (a) A person may not conduct business in the state as a pharmacy 03 benefits manager unless the person is registered with the director as a third-party 04 administrator under AS 21.27.630. 05 (b) A pharmacy benefits manager registered under AS 21.27.630 may 06 (1) contract with an insurer to administer or manage pharmacy benefits 07 provided by an insurer for a covered person, including claims processing services for 08 and audits of payments for prescription drugs and medical devices and supplies; 09 (2) contract with network pharmacies; 10 (3) set the cost of multi-source generic drugs under AS 21.27.945; and 11 (4) adjudicate appeals related to multi-source generic drug 12 reimbursement. 13 Sec. 21.27.905. Renewal of registration. (a) A pharmacy benefits manager 14 shall biennially renew a registration with the director. 15 (b) To renew a registration under this section, a pharmacy benefits manager 16 shall pay a renewal fee established by the director. The director shall set the amount of 17 the renewal fee to allow the renewal and oversight activities of the division to be self- 18 supporting. 19 Sec. 21.27.910. Pharmacy audit procedural requirements. (a) When a 20 pharmacy benefits manager conducts an audit of the records of a pharmacy, the period 21 covered by the audit of a claim may not exceed two years from the date that the claim 22 was submitted to or adjudicated by the pharmacy benefits manager, whichever is 23 earlier. Except as required under AS 21.36.495, a claim submitted to or adjudicated by 24 a pharmacy benefits manager does not accrue interest during the audit period. 25 (b) A pharmacy benefits manager conducting an on-site audit shall give the 26 pharmacy written notice of at least 10 business days before conducting an initial audit. 27 (c) A pharmacy benefits manager may not conduct 28 (1) an audit during the first seven calendar days of any month unless 29 agreed to by the pharmacy; 30 (2) more than one on-site audit of a pharmacy within a 12-month 31 period; or
01 (3) on-site audits of more than 250 separate prescriptions at one 02 pharmacy within a 12-month period unless fraud by the pharmacy or an employee of 03 the pharmacy is alleged. 04 (d) If an audit involves clinical or professional judgment, the individual 05 conducting the audit must 06 (1) be a pharmacist who is licensed and in good standing under 07 AS 08.80; or 08 (2) conduct the audit in consultation with a pharmacist who is licensed 09 and in good standing under AS 08.80. 10 (e) A pharmacy, in responding to an audit, may use 11 (1) verifiable statements or records, including medication 12 administration records of a nursing home, assisted living facility, hospital, physician, 13 or other authorized practitioner, to validate the pharmacy record; 14 (2) a legal prescription to validate claims in connection with 15 prescriptions, refills, or changes in prescriptions, including medication administration 16 records, prescriptions transmitted by facsimile, electronic prescriptions, or 17 documented telephone calls from the prescriber or the prescriber's agent. 18 (f) A pharmacy benefits manager shall audit each pharmacy under the same 19 standards and parameters as other similarly situated pharmacies in a network 20 pharmacy contract in this state. 21 Sec. 21.27.915. Overpayment or underpayment. (a) When a pharmacy 22 benefits manager conducts an audit of a pharmacy, the pharmacy benefits manager 23 shall base a finding of overpayment or underpayment by the pharmacy on the actual 24 overpayment or underpayment and not on a projection based on the number of patients 25 served having a similar diagnosis or on the number of similar orders or refills for 26 similar drugs, except as provided in (b) of this section. 27 (b) A pharmacy benefits manager may resolve a finding of overpayment or 28 underpayment by entering into a settlement agreement with the pharmacy. The 29 settlement agreement 30 (1) must comply with the requirements of AS 21.36.125; and 31 (2) may be based on a statistically justifiable projection method.
01 (c) A pharmacy benefits manager may not include the dispensing fee amount 02 in a finding of an overpayment unless 03 (1) a prescription was not actually dispensed; 04 (2) the prescriber denied authorization; 05 (3) the prescription dispensed was a medication error by the pharmacy; 06 or 07 (4) the identified overpayment is solely based on an extra dispensing 08 fee. 09 Sec. 21.27.920. Recoupment. (a) When a pharmacy benefits manager 10 conducts an audit of a pharmacy, the pharmacy benefits manager shall base the 11 recoupment of overpayments on the actual overpayment of the claim, except as 12 provided in AS 21.27.915(b). 13 (b) A pharmacy benefits manager conducting an audit of a pharmacy may not 14 (1) use extrapolation in calculating recoupments or penalties for audits, 15 unless required by state or federal contracts; 16 (2) assess a charge-back, recoupment, or other penalty against a 17 pharmacy solely because a prescription is mailed or delivered at the request of a 18 patient; or 19 (3) receive payment 20 (A) based on a percentage of the amount recovered; or 21 (B) for errors that have no actual financial harm to the patient 22 or medical plan. 23 Sec. 21.27.925. Pharmacy audit reports. (a) A pharmacy benefits manager 24 shall deliver a preliminary audit report to the pharmacy audited within 60 days after 25 the conclusion of the audit. 26 (b) A pharmacy benefits manager shall allow the pharmacy at least 30 days 27 following receipt of the preliminary audit report to provide documentation to the 28 pharmacy benefits manager to address a discrepancy found in the audit. A pharmacy 29 benefits manager may grant a reasonable extension upon request by the pharmacy. 30 (c) A pharmacy benefits manager shall deliver a final audit report to the 31 pharmacy within 120 days after receipt of the preliminary audit report, settlement
01 agreement, or final appeal, whichever is latest. 02 Sec. 21.27.930. Pharmacy audit appeal; future repayment. (a) A pharmacy 03 benefits manager conducting an audit shall establish a written appeals process. 04 (b) Recoupment of disputed funds or repayment of funds to the pharmacy 05 benefits manager by the pharmacy, if permitted by contract, shall occur, to the extent 06 demonstrated or documented in the pharmacy audit findings, after final internal 07 disposition of the audit, including the appeals process. If the identified discrepancy for 08 an individual audit exceeds $15,000, future payments to the pharmacy may be 09 withheld pending finalization of the audit. 10 (c) A pharmacy benefits manager may not assess against a pharmacy a charge- 11 back, recoupment, or other penalty until the pharmacy benefits manager's appeals 12 process has been exhausted and the final report or settlement agreement issued. 13 Sec. 21.27.935. Fraudulent activity. When a pharmacy benefits manager 14 conducts an audit of a pharmacy, the pharmacy benefits manager may not consider 15 unintentional clerical or record-keeping errors, including typographical errors, writer's 16 errors, or computer errors regarding a required document or record, to be fraudulent 17 activity. In this section, "fraudulent activity" means an intentional act of theft, 18 deception, misrepresentation, or concealment committed by the pharmacy. 19 Sec. 21.27.940. Pharmacy audits; restrictions. The requirements of 20 AS 21.27.901 - 21.27.955 do not apply to an audit 21 (1) in which suspected fraudulent activity or other intentional or wilful 22 misrepresentation is evidenced by a physical review, a review of claims data, a 23 statement, or another investigative method; or 24 (2) of claims paid for under the medical assistance program under 25 AS 47.07. 26 Sec. 21.27.945. Drug pricing list; procedural requirements. (a) A pharmacy 27 benefits manager shall 28 (1) make available to each network pharmacy at the beginning of the 29 term of the network pharmacy's contract, and upon renewal of the contract, the 30 methodology and sources used to determine the drug pricing list; 31 (2) provide a telephone number at which a network pharmacy may
01 contact an employee of a pharmacy benefits manager to discuss the pharmacy's 02 appeal; 03 (3) provide a process for a network pharmacy to have ready access to 04 the list specific to that pharmacy; 05 (4) review and update applicable list information at least once every 06 seven business days to reflect modification of list pricing; 07 (5) update list prices within one business day after a significant price 08 update or modification provided by the pharmacy benefits manager's national drug 09 database provider; and 10 (6) ensure that dispensing fees are not included in the calculation of the 11 list pricing. 12 (b) When establishing a list, the pharmacy benefits manager shall use 13 (1) the most up-to-date pricing data to calculate reimbursement to a 14 network pharmacy for drugs subject to list prices; 15 (2) multi-source generic drugs that are sold or marketed in the state 16 during the list period. 17 Sec. 21.27.950. Multi-source generic drug appeal. (a) A pharmacy benefits 18 manager shall establish a process by which a network pharmacy, or a network 19 pharmacy's contracting agent, may appeal the reimbursement for a multi-source 20 generic drug. A pharmacy benefits manager shall resolve an appeal from a network 21 pharmacy within 10 calendar days after the network pharmacy or the contracting agent 22 submits the appeal. 23 (b) A network pharmacy, or a network pharmacy's contracting agent, may 24 appeal a reimbursement from a pharmacy benefits manager for a multi-source generic 25 drug if the reimbursement for the drug is less than the amount that the network 26 pharmacy can purchase from two or more of its contracted suppliers. 27 (c) A pharmacy benefits manager may grant a network pharmacy's appeal if 28 an equivalent multi-source generic drug is not available at a price at or below the 29 pharmacy benefits manager's list price for purchase from national or regional 30 wholesalers who operate in the state. If an appeal is granted, the pharmacy benefits 31 manager shall adjust the reimbursement of the network pharmacy to equal the network
01 pharmacy acquisition cost for each paid claim included in the appeal. 02 (d) If the pharmacy benefits manager denies a network pharmacy's appeal, the 03 pharmacy benefits manager shall provide the network pharmacy with the 04 (1) reason for the denial; 05 (2) national drug code of an equivalent multi-source generic drug that 06 has been purchased by another network pharmacy located in the state at a price that is 07 equal to or less than the pharmacy benefits manager's list price within seven days after 08 the network pharmacy appeals the claim; and 09 (3) name of a pharmaceutical wholesaler who operates in the state in 10 which the drug may be acquired by the challenging network pharmacy. 11 (e) A network pharmacy may request a hearing under AS 21.06.170 - 12 21.06.240 for an adverse decision from a pharmacy benefits manager within 30 13 calendar days after receiving the decision. The parties may present all relevant 14 information to the director for the director's review. 15 (f) The director shall enter an order that 16 (1) grants the network pharmacy's appeal and directs the pharmacy 17 benefits manager to make an adjustment to the disputed claim; 18 (2) denies the network pharmacy's appeal; or 19 (3) directs other actions considered fair and equitable. 20 Sec. 21.27.955. Definitions. In AS 21.27.901 - 21.27.955, 21 (1) "audit" means an official examination and verification of accounts 22 and records; 23 (2) "claim" means a request from a pharmacy or pharmacist to be 24 reimbursed for the cost of filling or refilling a prescription for a drug or for providing 25 a medical supply or device; 26 (3) "extrapolation" means the practice of inferring a frequency or 27 dollar amount of overpayments, underpayments, invalid claims, or other errors on any 28 portion of claims submitted, based on the frequency or dollar amount of 29 overpayments, underpayments, invalid claims, or other errors actually measured in a 30 sample of claims; 31 (4) "list" means the list of multi-source generic drugs for which a
01 predetermined reimbursement amount has been established such as a maximum 02 allowable cost or maximum allowable cost list or any other list of prices used by a 03 pharmacy benefits manager; 04 (5) "multi-source generic drug" means any covered outpatient 05 prescription drug that the United States Food and Drug Administration has determined 06 is pharmaceutically equivalent or bioequivalent to the originator or name brand drug 07 and for which there are at least two drug products that are rated as therapeutically 08 equivalent under the United States Food and Drug Administration's most recent 09 publication of "Approved Drug Products with Therapeutic Equivalence Evaluations"; 10 (6) "network pharmacy" means a pharmacy that provides covered 11 health care services or supplies to an insured or a member under a contract with a 12 network plan to act as a participating provider; 13 (7) "pharmacy" has the meaning given in AS 08.80.480; 14 (8) "pharmacy acquisition cost" means the amount that a 15 pharmaceutical wholesaler or distributor charges for a pharmaceutical product as listed 16 on the pharmacy's invoice; 17 (9) "pharmacy benefits manager" means a person that contracts with a 18 pharmacy on behalf of an insurer to process claims or pay pharmacies for prescription 19 drugs or medical devices and supplies or provide network management for 20 pharmacies; 21 (10) "recoupment" means the amount that a pharmacy must remit to a 22 pharmacy benefits manager when the pharmacy benefits manager has determined that 23 an overpayment to the pharmacy has occurred. 24 * Sec. 6. The uncodified law of the State of Alaska is amended by adding a new section to 25 read: 26 APPLICABILITY. (a) AS 21.27.901 - 21.27.955, enacted by sec. 5 of this Act, apply 27 to audits of pharmacies conducted by pharmacy benefits managers and contracts entered into 28 or renewed on or after the effective date of sec. 5 of this Act. 29 (b) AS 08.80.297(b), enacted by sec. 1 of this Act, applies to contracts entered into or 30 renewed on or after the effective date of sec. 1 of this Act. 31 (c) In this section, "pharmacy" and "pharmacy benefits manager" have the meanings
01 given in AS 21.27.955, enacted by sec. 5 of this Act. 02 * Sec. 7. The uncodified law of the State of Alaska is amended by adding a new section to 03 read: 04 TRANSITIONAL PROVISIONS: REGULATIONS. The division of insurance may 05 adopt regulations necessary to implement the changes made by this Act. The regulations take 06 effect under AS 44.62 (Administrative Procedure Act), but not before the effective date of the 07 law implemented by the regulation. 08 * Sec. 8. The uncodified law of the State of Alaska is amended by adding a new section to 09 read: 10 REVISOR'S INSTRUCTIONS. The revisor of statutes is requested to renumber 11 AS 21.27.900 as AS 21.27.990. The revisor of statutes is requested to change "AS 21.27.900" 12 to "AS 21.27.990" in AS 21.36.475(c)(2) and (4) and AS 21.97.900(27). 13 * Sec. 9. Sections 1, 3, and 6(b) of this Act take effect immediately under AS 01.10.070(c). 14 * Sec. 10. Except as provided in sec. 9 of this Act, this Act takes effect July 1, 2019.